My first first-author paper is out on JITC! Thank you to everyone involved, especially the patients that provided us their samples for this study, & Mike for the opportunity. @bailey-bye.bsky.social @mruckert.bsky.social @VansaunLab.bsky.social bsky.app/profile/sitc... #PDAC #scisky #science

New Journal for ImmunoTherapy of Cancer (JITC) article: Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer bit.ly/4bZUKWM @bailey-bye.bsky.social @mruckert.bsky.social #JITC #MedSky #OncSky #pancreatic #therapy